These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 16953832)

  • 21. Discrimination between neoplastic and non-neoplastic lesions in cirrhotic liver using contrast-enhanced ultrasound.
    Xu HX; Lu MD; Liu LN; Zhang YF; Guo LH; Xu JM; Liu C
    Br J Radiol; 2012 Oct; 85(1018):1376-84. PubMed ID: 22553290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contrast-enhanced sonography in the diagnosis of small hepatocellular carcinoma < or =2 cm.
    Xu HX; Xie XY; Lu MD; Liu GJ; Xu ZF; Zheng YL; Liang JY; Chen LD
    J Clin Ultrasound; 2008 Jun; 36(5):257-66. PubMed ID: 18088056
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnosis of benign and malignant portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma: color Doppler US, contrast-enhanced US, and fine-needle biopsy.
    Tarantino L; Francica G; Sordelli I; Esposito F; Giorgio A; Sorrentino P; de Stefano G; Di Sarno A; Ferraioli G; Sperlongano P
    Abdom Imaging; 2006; 31(5):537-44. PubMed ID: 16865315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CEUS: An essential component in a multimodality approach to small nodules in patients at high-risk for hepatocellular carcinoma.
    Jang HJ; Kim TK; Burns PN; Wilson SR
    Eur J Radiol; 2015 Sep; 84(9):1623-35. PubMed ID: 26092406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Small hepatocellular carcinomas in cirrhosis: differences in contrast enhancement effects between helical CT and MR imaging during multiphasic dynamic imaging.
    Hayashida M; Ito K; Fujita T; Shimizu A; Sasaki K; Tanabe M; Matsunaga N
    Magn Reson Imaging; 2008 Jan; 26(1):65-71. PubMed ID: 17566685
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High frame-rate contrast enhanced ultrasound (HIFR-CEUS) in the characterization of small hepatic lesions in cirrhotic patients.
    Giangregorio F; Garolfi M; Mosconi E; Ricevuti L; Debellis MG; Mendozza M; Esposito C; Vigotti E; Cadei D; Abruzzese D
    J Ultrasound; 2023 Mar; 26(1):71-79. PubMed ID: 36227456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Significance of hyperattenuating and contrast-enhancing hepatic nodules detected in the cirrhotic liver during arterial phase helical CT in pre-liver transplant patients: radiologic-histopathologic correlation of explanted livers.
    Freeny PC; Grossholz M; Kaakaji K; Schmiedl UP
    Abdom Imaging; 2003; 28(3):333-46. PubMed ID: 12719903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. B-mode and contrast enhanced ultrasound guided biopsy of portal vein thrombosis. Value in the diagnosis of occult hepatocellular carcinoma in liver cirrhosis.
    Sparchez Z; Radu P; Zaharia T; Kacso G; Diaconu B; Grigorescu I; Badea R
    Med Ultrason; 2010 Dec; 12(4):286-94. PubMed ID: 21210013
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of pathological features of hepatocellular carcinoma by contrast-enhanced ultrasonography: comparison with pathology on resected specimen.
    Ogawa S; Kumada T; Toyoda H; Ichikawa H; Kawachi T; Otobe K; Hibi T; Takeshima K; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Yamaguchi A; Isogai M; Kaneoka Y; Washizu J
    Eur J Radiol; 2006 Jul; 59(1):74-81. PubMed ID: 16545532
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dynamic contrast-enhanced ultrasound (DCE-US) for easy and rapid evaluation of hepatocellular carcinoma compared to dynamic contrast-enhanced computed tomography (DCE-CT)--a pilot study.
    Egger C; Goertz RS; Strobel D; Lell M; Neurath MF; Knieling F; Scharf M
    Ultraschall Med; 2012 Dec; 33(6):587-92. PubMed ID: 23154871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of CEUS in the characterization of hepatocellular nodules detected during the US surveillance program--current practices in Europe.
    Quaia E; Lorusso A; Grisi G; Stacul F; Cova MA
    Ultraschall Med; 2012 Jul; 33 Suppl 1():S48-56. PubMed ID: 22723029
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contrast-enhanced ultrasound in the diagnosis of hepatocellular carcinoma.
    Palmieri VO; Santovito D; Marano G; Minerva F; Ricci L; D'Alitto F; Angelelli G; Palasciano G
    Radiol Med; 2015 Jul; 120(7):627-33. PubMed ID: 25599661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of focal hepatic lesions in cirrhotic patients by Pulse Inversion Harmonic Imaging US contrast specific technique with Levovist.
    Quaia E; Forgács B; Calderan L; Bertolotto M; Pozzi Mucelli R
    Radiol Med; 2002 Oct; 104(4):285-94. PubMed ID: 12569309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validation of diagnostic criteria using gadoxetic acid-enhanced and diffusion-weighted MR imaging for small hepatocellular carcinoma (<= 2.0 cm) in patients with hepatitis-induced liver cirrhosis.
    Park MJ; Kim YK; Lee MH; Lee JH
    Acta Radiol; 2013 Mar; 54(2):127-36. PubMed ID: 23148300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Additional value of SPIO-enhanced MR imaging for the noninvasive imaging diagnosis of hepatocellular carcinoma in cirrhotic liver.
    Yoo HJ; Lee JM; Lee JY; Kim SH; Kim SJ; Han JK; Choi BI
    Invest Radiol; 2009 Dec; 44(12):800-7. PubMed ID: 19838119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Arterioportal shunt: prevalence in small hemangiomas versus that in hepatocellular carcinomas 3 cm or smaller at two-phase helical CT.
    Byun JH; Kim TK; Lee CW; Lee JK; Kim AY; Kim PN; Ha HK; Lee MG
    Radiology; 2004 Aug; 232(2):354-60. PubMed ID: 15215556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Arterial enhancing-only nodules less than 2 cm in diameter in patients with liver cirrhosis: predictors of hepatocellular carcinoma diagnosis on gadobenate dimeglumine-enhanced MR imaging.
    Quaia E; Pizzolato R; De Paoli L; Angileri R; Ukmar M; Cova MA
    J Magn Reson Imaging; 2013 Apr; 37(4):892-902. PubMed ID: 23097278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.
    Lee MH; Kim SH; Park MJ; Park CK; Rhim H
    AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differentiation of small hepatic hemangioma from small hepatocellular carcinoma: recently introduced spectral CT method.
    Lv P; Lin XZ; Li J; Li W; Chen K
    Radiology; 2011 Jun; 259(3):720-9. PubMed ID: 21357524
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma.
    Bolondi L; Gaiani S; Celli N; Golfieri R; Grigioni WF; Leoni S; Venturi AM; Piscaglia F
    Hepatology; 2005 Jul; 42(1):27-34. PubMed ID: 15954118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.